Khiron Life Sciences Corp

Ticker

KHRNF

Website

Sector

Healthcare

Why Invest

1. Leader in the emerging international medical cannabis markets of LatAm and Europe with over 1 billion people 2. Unique seed-to-patient, vertically-integrated strategy generating ~50% CMGR and >80% gross margins 3. Proven Colombian business model ready to be exported to new markets in LatAm and beyond 4. Increasing global execution with sales in 4 countries (Colombia, Peru, UK, Germany) and 2 more targeted by year end (Mexico and Brazil) 5. Experienced and diverse team with successful execution record & ability to understand and lead the global cannabis marketKhiron is a leading vertically integrated medical cannabis company with core operations in Latin America and Europe. Leveraging wholly-owned medical health centres and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure to drive prescriptions and brand loyalty with patients worldwide. The Company has a sales presence in Colombia, Peru, Germany and the UK, and is positioned to commence sales in Mexico and Brazil in 2021. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors. Visit Khiron online at investors.khiron.ca and on Instagram @khironlife.

  

  1. Leader in emerging medical cannabis markets in LatAm and Europe with over 50,000 medical cannabis prescriptions filled. Mexican market estimated to be at $2b